Where can I find the specific financial results for Gilead's first quarter of 2024?

The detailed financial results for the quarter ended March 31, 2024, are provided in the press release filed as Exhibit 99.1 to this 8-K filing.

What is the difference between GAAP and non-GAAP financial information mentioned in the filing?

GAAP (Generally Accepted Accounting Principles) are the standard accounting rules. Non-GAAP measures are alternative performance metrics that management believes offer additional insights but are not prepared under comprehensive accounting rules and may differ from how other companies calculate them. A reconciliation is provided in the press release to help understand the differences.

Why does Gilead provide non-GAAP financial information?

Gilead provides non-GAAP information because management uses these measures internally for operational, budgeting, and financial planning purposes, and believes they are useful for investors to supplement their understanding of the company's operating results.

Is the information in the press release considered part of a formal SEC filing for liability purposes?

No, the information contained in Item 2.02 and Exhibit 99.1 is specifically stated as not being 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it subject to the liabilities under that section.

GILD 8-K: Earnings & Results

Summary

Gilead Sciences, Inc. (GILD) filed an 8-K on April 25, 2024, to report its financial results for the first quarter ended March 31, 2024. The report primarily directs investors to a press release (Exhibit 99.1) for detailed financial performance, including both GAAP and non-GAAP measures. Management emphasizes the utility of non-GAAP figures for internal operational and financial planning, suggesting these provide valuable insights alongside the official GAAP statements for investors. Investors should refer to the press release for specific figures regarding revenue, earnings per share, and other key financial metrics for the quarter. The filing itself is procedural, confirming the release of these results and highlighting the availability of supplementary non-GAAP information. It's important for investors to review the provided reconciliation tables to understand the differences between GAAP and non-GAAP reporting.

Key Highlights

1Gilead Sciences announced its Q1 2024 financial results on April 25, 2024, via an 8-K filing.
2The primary source of detailed financial information is the press release filed as Exhibit 99.1.
3The company presented financial results using both GAAP and non-GAAP measures.
4Management believes non-GAAP measures are useful for investors and internal operational planning.
5A reconciliation between GAAP and non-GAAP financial information is available in the press release.
6The filing is procedural, informing the market of the earnings release.
7Information provided in Item 2.02 and Exhibit 99.1 is not considered 'filed' for Section 18 purposes.

GILEAD SCIENCES, INC. 8-K Report, Financial Results (Apr 25, 2024)

Summary

Key Highlights

Frequently Asked Questions